Clinical trials
Musculoskeletal Diseases or Conditions clinical trials
Below are recruiting musculoskeletal diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,026 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07809438RecruitingPhase 2
Comparing PET scans for early Parkinson's detection
This study tests two different PET scan resolutions to see which is better at detecting signs of early Parkinson's. It is for people who are already part of a Parkinson's research study and may help improve early diagnosis.
New Haven, ConnecticutAges 18 years+ - NCT07815249Recruiting
Speech therapy for children with rare genetic conditions and speech apraxia
This trial tests a speech therapy program for children with rare genetic conditions who also have childhood apraxia of speech, a disorder where the brain has trouble planning the movements needed for speech. The therapy is intensive—three sessions a week for four weeks—and may help improve your child's ability to speak clearly.
Melbourne, VictoriaAges 3–16 - NCT07814352RecruitingPhase 1
A study of SX-682 with proton radiation therapy for leptomeningeal disease
This trial tests a new drug (SX-682) combined with proton radiation therapy for people whose cancer has spread to the fluid around the brain and spinal cord. The goal is to see if this combination can help control the disease better. You can join if you have melanoma or non-small cell lung cancer that has spread.
Basking Ridge, New JerseyAges 18 years+ - NCT06492187Recruiting
Survey to see if you qualify for infectious disease studies
This trial is a quick survey to see if you might be eligible for future infectious disease studies. It helps researchers understand your health background and find the right study for you.
Brooklyn, New YorkAges 18 years+ - NCT06497387RecruitingEarly Phase 1
PRG-1801 for stubborn lupus kidney and IgG4 disease
This trial tests a new treatment called PRG-1801 for people with lupus nephritis (kidney inflammation from lupus) or IgG4-related disease that has not improved with standard treatments. The treatment uses your own immune cells to target and calm the disease.
Wuhan, HubeiAges 18 years+ - NCT06497361RecruitingEarly Phase 1
PRG-2311 for hard-to-treat lupus nephritis and IgG4 disease
This trial tests a new treatment called PRG-2311 for people with lupus nephritis or IgG4-related disease that has not responded to standard therapies. The treatment uses a type of immune cell therapy (CAR-T) to try to control the disease.
Wuhan, HubeiAges 18 years+ - NCT07802509Recruiting
summary
safeEffectiveness
Valens, Canton of St. GallenAges 18 years+ - NCT07793409RecruitingPhase 3
Long-term safety study of lunsekimig for COPD
This study is a long-term follow-up for people with COPD who have already completed an earlier lunsekimig study. It aims to check the safety and effectiveness of the treatment over a longer period.
Newport Beach, CaliforniaAges 40–80 - NCT07798271Recruiting
Optimizing deep brain stimulation for Parkinson's disease
This study is for people with Parkinson's disease who already have a deep brain stimulator (a device that sends electrical pulses to the brain) and still have motor fluctuations (times when symptoms come and go). The researchers want to see if adapting the device's settings can better control symptoms than the current standard settings.
Davis, CaliforniaAges 18 years+ - NCT07796217RecruitingPhase 4
Comparing blood thinners after a heart attack
This study compares two ways to lower the chances of another heart attack: taking the standard medicine (clopidogrel) versus taking a combination of aspirin and a lower dose of a blood thinner (rivaroxaban). If you join, you'll be assigned to one of these options to see which works better for people like you.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT07794800Recruiting
Observing eye complications after stem cell transplant
This study observes patients who have had a stem cell transplant to understand and monitor chronic graft-versus-host disease affecting the eyes. It aims to learn more about this condition to improve future care.
Shanghai, Shanghai MunicipalityAges 14 years+ - NCT07787299Recruiting
Wearable sensors for monitoring tremor in Parkinson's disease
This study tests whether wearable sensors can accurately measure tremor and other movement symptoms in people with Parkinson's disease or essential tremor. Participating may help improve how doctors monitor symptoms at home.
Edinburgh, EdinburghAges 18 years+ - NCT07787169RecruitingPhase 1
Study of amyloid-targeting therapies for Alzheimer's disease
This study tests several new experimental medications that target amyloid plaques, the protein clumps linked to Alzheimer's disease. It aims to find out if these treatments are safe and well-tolerated in people with early-stage Alzheimer's and in healthy volunteers.
Anaheim, CaliforniaAges 18–85 - NCT07791043RecruitingPhase 2
Efimosfermin alfa for alcohol-related liver disease
This study tests an investigational medicine called efimosfermin alfa to see if it is safe and effective for people with liver damage caused by heavy drinking. The medicine is compared to a placebo (a dummy treatment).
Topeka, KansasAges 18–75 - NCT07780383RecruitingPhase 1
Single-dose study for healthy adults and early Alzheimer's participants
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
Anaheim, CaliforniaAges 18–80 - NCT07775794Recruiting
Moderate exercise for quiet bowel disease
This study looks at whether a moderate exercise program can help people with inflammatory bowel disease (IBD) feel better and manage their condition. It aims to see if exercise improves overall health without worsening symptoms.
Bangkok Noi, BangkokAges 18–65 - NCT07781579Recruiting
MRI study to predict bleeding risk in moyamoya disease
This study uses advanced MRI scans to better predict the risk of bleeding in people with moyamoya disease, a rare condition where brain arteries narrow. It aims to improve prevention of bleeding strokes.
Beijing, Beijing MunicipalityAges Any age - NCT06540989RecruitingEarly Phase 1
Speech therapy with computer feedback for Parkinson's
This study tests a new speech therapy approach for people with Parkinson's disease who have mild to moderate speech problems. It uses a computer program that listens to your speech and helps you practice speaking more clearly.
New York, New YorkAges 50–80 - NCT07774312Recruiting
Comparing tTIS treatment intervals to standard care for Parkinson's
This study compares different schedules of a non-invasive brain stimulation treatment (called tTIS) to standard medication for Parkinson's disease. It aims to find the best timing for tTIS to improve motor symptoms.
Shanghai, Shanghai MunicipalityAges 50–85 - NCT07766434Recruiting
Registry for heart artery blockage treatment
This study looks at real-world outcomes for people with narrowed heart arteries (coronary artery disease). It may include those treated with stents (PCI) or medicines. Doctors will use a special computer tool to measure the severity of blockages and track health over time.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07759167RecruitingPhase 1
Study of three study drugs for kidney failure patients on dialysis
This trial tests three experimental antibodies given to people with end-stage kidney disease who are on hemodialysis. It aims to see if these drugs are safe and how they affect blood clotting in this group.
Ghent, Oost-VlaanderenAges 18 years+ - NCT07764146RecruitingPhase 1
Study of VY1706 for early Alzheimer's disease
This study tests an experimental treatment called VY1706 for people with early Alzheimer's disease. It aims to see if the treatment is safe and how well it works, and may help slow down the disease.
Maitland, FloridaAges 30–80 - NCT07758595RecruitingPhase 1
Study of DNL921 for healthy people and people with Alzheimer's disease
This trial tests an investigational drug called DNL921 in healthy volunteers and in people with mild to moderate Alzheimer's disease. The goal is to see if it is safe and how the body handles it, which is a first step in finding a new treatment.
ManchesterAges 18–75 - NCT07759245RecruitingPhase 2
Brenipatide for moderate-to-severe COPD
This trial tests a new medicine called Brenipatide to see if it can help people with moderate-to-severe COPD who still have symptoms despite using standard inhalers. The study will compare the effects of Brenipatide against a placebo to understand if it is safe and effective.
Birmingham, AlabamaAges 40–75
Hear when a new Musculoskeletal Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for musculoskeletal diseases or conditions?
- Yes. Clin2 currently lists 4,026 recruiting musculoskeletal diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a musculoskeletal diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a musculoskeletal diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.